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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S263a capsule per randomization schedule. After 2 hours subjects began
a series of two additional SP walks followed by a high paced (HP) walk,
at 30% faster pace than their SP walk. Prior to (t ¼ 0) and every 3
minutes after each walk initiation the subjects were queried for their
current KOA PI score. Primary endpoint time weighted average pain
scores on the treadmill (TWAP), used to estimate differences in average
pain scores (APS) between P and N treatments. Secondary endpoints:
included changes in WOMAC 3.1 VAS scores, Investigator Global
Assessment of Disease Status (IGADS) and adverse events (AEs). Other
assessments included surface joint temperature and algometry. Statis-
tical analyses included a mixed effect model with ﬁxed effects for
period and treatment and random effect for subject with carryover
investigated in a sensitivity analysis. For the analysis of WOMAC scores
the pre-treatment baselines recorded in each period were included as
two covariates representing the individual's average baseline and the
difference from this average.
Results: In randomized KOA subjects (N¼23), there were signiﬁcant
treatment effects during naproxen treatment vs placebo treatment at t
¼ 0 and during the treadmill walk, noted in APS by TWAP andWOMAC.
The most sensitive endpoints, were t¼0 values (N vs P: APS -0.93(CI:
-1.52, -0.34), p¼0.004, on 3rd SP walk. Increased effect size by TWAP
was seen in the HP walks (N vs P: -1.02; (CI: -1.61, -0.43), p¼0.002).
WOMAC Pain scores at the start of the study were 53.4 (sd 15.8). Total
WOMAC and all subscale scores showed signiﬁcant differences between
naproxen and placebo. The treadmill walking scores maintained the
APS treatment differences but did not capture additional (dynamic)
analgesic signals. IGADS scores also reﬂected treatment differences.
Conclusions: The modiﬁed walking model showed pain intensity
differences between treatments at t¼0 and during treadmill in a rela-
tively small KOA population. The modiﬁcations expedited enrollment
and time to completion but limited interpretation of pain on walking.
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PREDICTORS FOR THE PROGRESSION OF KNEE PAIN IN SUBJECTS
WITH EARLY SYMPTOMATIC KNEE OSTEOARTHRITIS - FIVE YEAR
RESULTS FROM THE CHECK STUDY
A.N. Bastick y, S. Verkleij y, J. Damen y, J. Wesseling z, P.J. Emans x, S.M.
Bierma-Zeinstra y. 1 Erasmus Univ. Med. Ctr., Rotterdam, The
Netherlands; 2Univ. Med. Ctr. Utrecht, Utrecht, The Netherlands; 3Univ.
Hosp. Maastricht, Maastricht, The Netherlands
Purpose: To determine which patient- or disease characteristics can
help predict future pain trajectories in patients with early symptomatic
osteoarthritis of the knee (knee OA).
Methods: The data were acquired from the Cohort Hip and Cohort Knee
(CHECK) study, a prospective follow-up cohort of 1002 participants
with early symptomatic knee and/or hip OA. We restricted ourselves to
participants who had knee pain; knee OA according to the ACR criteria;
and a completed follow-up period. Baseline characteristics were
assessed. The outcome measure was pain assessed by the Visual
Analogue Score (VAS) over a ﬁve year period. The participants were
categorized into three distinct pain trajectories retrieved by latent class
growth analysis. This resulted in a favourable; a stable; and an unfav-
ourable course of pain group. Multinomial logistic regression analyses
were performed univariately and multivariately to calculate odds ratios
(ORs) and corresponding 95% conﬁdence intervals (95% CI) in order to
estimate the association of baseline variables with the distinct trajec-
tories. Additionally a subanalysis was performed for smaller subgroups
with more extreme courses of pain.
Results: 705 participants were included in our analyses (¼ 705 knees).
Therewere signiﬁcant differences between the pain trajectory groups in
how participants cope with pain. Four variables remained statistically
signiﬁcant after the univariate and the multivariable analyses between
the unfavourable and the favourable course of pain group: number of co
morbidities (> 1 vs.  1) (OR 2.2 [1.2-4.1]); baseline VAS (OR 1.8 [1.5-
2.1]); pain during active ﬂexion of the knee (yes vs. no) (OR 2.2 [1.0-
4.5]); and joint space tenderness of the index knee during physical
examination (yes vs. no) (OR 2.1 [1.1-3.8]). The subanalysis showed
similar signiﬁcant variables.
Conclusions: Individuals with early symptomatic knee OAwho present
with more severe joint pain; lesser capability to cope with pain; multi
morbidity; joint space tenderness of the index knee; pain in the ipsi-
lateral hip; and painful range of motion of the ipsilateral hip have an
increased risk of progression of knee pain during a ﬁve year follow-up
period.509
INVESTIGATION OF THE RELATIONSHIP BETWEEN HIP BONE
MARROW LESIONS, HIGH CARTILAGE SIGNAL AND HIP AND KNEE
PAIN IN TWO POPULATION-BASED COHORTS
H. Ahedi y, D. Dore y, L. Blizzard y, F. Cicuttini z, G. Jones y. yMenzies Res.
Inst., Univ. of Tasmania, Hobart, Tasmania, Australia; zDEPM, Sch. of
Publ. Hlth. and Preventive Med., Monash Univ., Melbourne, Australia
Aim: To examine the relationship between hip BMLs, high cartilage
signal and hip and knee pain using data from two geographically
different cohorts.
Methods: The ﬁrst cohort included 143 healthy subjects from the
Melbourne Collaborative Cohort study (MCCS) with a right hip MRI
conducted during 2009-2010. The second cohort involved 198 subjects
from Tasmanian Older Adult Cohort (TASOAC) with right hip MRI con-
ducted at two time points, approx. 2.6 years apart. Subjects inMCCS had
a T2-weighted MRI sequence and those in TASOAC had a Short T1
Inversion Recovery (STIR) MRI sequence. These MRI images were used
to quantitatively assess hip BMLs size and determine high cartilage
signal presence. Hip WOMAC (Western Ontario and McMaster Univer-
sities Osteoarthritis) was assessed in both cohorts, but knee WOMAC
was available only in TASOAC. Log binomial regression was used to
estimate the relative risk (RR) of presence of pain and of high cartilage
signal, and linear regressionwas used in the analysis of severity of pain.
Results: In the MCCS, 17% (24/143) of subjects had femoral and/or
acetabular BML. Presence of any acetabular BML (n¼20, 13%) was
associated with higher relative risk of hip pain [RR: 1.17, 95% CI: 1.03,
1.17]. Having a large femoral BML was associated with more severe hip
pain [mean difference in hip pain score: 40.6, 95% CI: 6.00, 75.3]. Hip
BML size was not associated with either hip or knee pain. In TASOAC,
28% (55/198) of subjects had a hip BML at either or both sites. In cross-
sectional analysis, presence of any large BML (n¼14, 8%) was associated
with higher risk of hip pain [RR 2.14, 95% CI: 1.34, 3.41] and having
a large acetabular BMLwas associatedwith greater severity of knee pain
[mean diff 2.11, 95% CI: 0.36, 3.84] and greater hip pain [mean diff 3.92,
95% CI: 1.63, 9.57]. Longitudinally, resolution of femoral BMLs was
associated with a decrease in hip [mean diff  2.75, 95% CI: 4.52,
0.99] and knee [mean diff 3.46, 95% CI: 5.91, 0.88] pain while
incident acetabular [mean diff +5.84, 95% CI: +3.63, +8.05] and femoral
[mean diff +0.98, 95% CI: +0.28, +1.78] BMLs were associated with
worsening hip pain. High cartilage signal was associated with hip BMLs
in each cohort [MCCS, RR: 1.70 95% CI: 1.41, 2.11; TASOAC, RR 1.79 95%
CI: 1.52, 1.92] but not with pain.
Conclusion: The consistent cross-sectional evidence from the MCCS
and TASOAC cohorts, which was conﬁrmed by longitudinal results from
the TASOAC cohort, suggests that large hip BMLs are associated with
both hip and knee pain. High cartilage signal was asymptomatic but
strongly associated with hip BMLs.
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ASSOCIATIONS OF FREQUENT PREDICTABLE AND UNPREDICTABLE
PAIN WITH FUNCTIONAL AND PSYCHOLOGICAL OUTCOMES
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Purpose: Studies have shown that greater pain severity is associated
with poorer functional and psychological outcomes among patients
with osteoarthritis (OA), but little is known about the impact of other
aspects of the pain experience. This study examined associations of the
frequency of predictable (e.g., occurs after a speciﬁc trigger) and
unpredictable (e.g., occurs without warning) pain with self-reported
functional outcomes and depressive symptoms among patients with
physician diagnoses of hip and/or knee OA.
Methods: Participants were n¼293 patients enrolled in a clinical trial of
a combined patient and provider intervention for managing OA at the
Durham Veterans Affairs Medical Center (mean age ¼ 61, SD¼9, 90%
male, 53% non-white - primarily African American). All measures were
from baseline assessments. The frequency of predictable and unpre-
dictable pain were assessed with two items from the Measure of
Intermittent and Constant Osteoarthritis Pain Index (ICOAP), both
categorized as frequent (often, very often) vs. infrequent (never, rarely,
sometimes). Physical function outcomes included the Western Ontario
and McMasters University Osteoarthritis Index (WOMAC) function
subscale and the Satisfaction with Physical Function Scale. Depressive
